X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs WOCKHARDT LTD. - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD WOCKHARDT LTD. STRIDES SHASUN LTD/
WOCKHARDT LTD.
 
P/E (TTM) x 15.2 -18.3 - View Chart
P/BV x 1.8 3.0 58.5% View Chart
Dividend Yield % 0.6 1.1 51.3%  

Financials

 STRIDES SHASUN LTD   WOCKHARDT LTD.
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
WOCKHARDT LTD.
Mar-17
STRIDES SHASUN LTD/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,2751,129 112.9%   
Low Rs918627 146.4%   
Sales per share (Unadj.) Rs389.6363.1 107.3%  
Earnings per share (Unadj.) Rs28.0-20.4 -136.8%  
Cash flow per share (Unadj.) Rs48.9-7.0 -701.0%  
Dividends per share (Unadj.) Rs4.5010.00 45.0%  
Dividend yield (eoy) %0.41.1 36.0%  
Book value per share (Unadj.) Rs303.1301.8 100.4%  
Shares outstanding (eoy) m89.42110.55 80.9%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x2.82.4 116.4%   
Avg P/E ratio x39.2-42.9 -91.3%  
P/CF ratio (eoy) x22.4-125.9 -17.8%  
Price / Book Value ratio x3.62.9 124.3%  
Dividend payout %16.1-48.9 -32.9%   
Avg Mkt Cap Rs m98,03697,063 101.0%   
No. of employees `0005.86.8 85.7%   
Total wages/salary Rs m5,8819,665 60.8%   
Avg. sales/employee Rs Th6,005.95,931.8 101.2%   
Avg. wages/employee Rs Th1,014.01,428.1 71.0%   
Avg. net profit/employee Rs Th431.2-334.0 -129.1%   
INCOME DATA
Net Sales Rs m34,83440,146 86.8%  
Other income Rs m1,6861,143 147.6%   
Total revenues Rs m36,52041,289 88.5%   
Gross profit Rs m6,428128 5,021.9%  
Depreciation Rs m1,8721,489 125.7%   
Interest Rs m2,2692,253 100.7%   
Profit before tax Rs m3,973-2,472 -160.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470-211 -222.6%   
Profit after tax Rs m2,501-2,260 -110.6%  
Gross profit margin %18.50.3 5,787.7%  
Effective tax rate %11.88.5 138.5%   
Net profit margin %7.2-5.6 -127.5%  
BALANCE SHEET DATA
Current assets Rs m38,16546,160 82.7%   
Current liabilities Rs m30,40219,258 157.9%   
Net working cap to sales %22.367.0 33.3%  
Current ratio x1.32.4 52.4%  
Inventory Days Days77101 76.8%  
Debtors Days Days10494 111.1%  
Net fixed assets Rs m37,63940,165 93.7%   
Share capital Rs m894553 161.8%   
"Free" reserves Rs m26,21032,814 79.9%   
Net worth Rs m27,10533,367 81.2%   
Long term debt Rs m16,37731,903 51.3%   
Total assets Rs m81,16889,687 90.5%  
Interest coverage x2.8-0.1 -2,832.1%   
Debt to equity ratio x0.61.0 63.2%  
Sales to assets ratio x0.40.4 95.9%   
Return on assets %5.90 -68,452.9%  
Return on equity %9.2-6.8 -136.2%  
Return on capital %12.1-0.3 -3,595.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,4659,121 147.6%   
Fx outflow Rs m4,0762,133 191.1%   
Net fx Rs m9,3896,988 134.4%   
CASH FLOW
From Operations Rs m2,881-2,695 -106.9%  
From Investments Rs m-7,051-6,863 102.7%  
From Financial Activity Rs m3,38212,545 27.0%  
Net Cashflow Rs m-7883,010 -26.2%  

Share Holding

Indian Promoters % 27.7 74.5 37.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 2.3 1,643.5%  
FIIs % 8.6 7.7 111.7%  
ADR/GDR % 0.0 0.1 -  
Free float % 25.9 15.4 168.2%  
Shareholders   56,241 67,757 83.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Positive Note; Apollo Micro Systems IPO Lists at 74% Premium(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the energy sector and IT sector witnessing maximum buying interest.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 22, 2018 01:57 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS